The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Phosphorylation of Thr 495 Regulates Ca 2+ /Calmodulin-Dependent Endothelial Nitric Oxide Synthase Activity
Abstract
Abstract —The activity of the endothelial nitric oxide synthase (eNOS) can be regulated independently of an increase in Ca 2+ by the phosphorylation of Ser 1177 but results only in a low nitric oxide (NO) output. In the present study, we assessed whether the agonist-induced (Ca 2+ -dependent, high-output) activation of eNOS is associated with changes in the phosphorylation of Thr 495 in the calmodulin (CaM)-binding domain. eNOS Thr 495 was constitutively phosphorylated in porcine aortic endothelial cells and was rapidly dephosphorylated after bradykinin stimulation. In the same cells, bradykinin enhanced the phosphorylation of Ser 1177 , which was maximal after 5 minutes, and abolished by the CaM-dependent kinase II (CaMKII) inhibitor KN-93. Bradykinin also enhanced the association of CaMKII with eNOS. Phosphorylation of Thr 495 was attenuated by the protein kinase C (PKC) inhibitor Ro 31-8220 and after PKC downregulation using phorbol 12-myristate 13-acetate. The agonist-induced dephosphorylation of Thr 495 was completely Ca 2+ -dependent and inhibited by the PP1 inhibitor calyculin A. Little CaM was bound to eNOS immunoprecipitated from unstimulated cells, but the agonist-induced dephosphorylation of Thr 495 enhanced the association of CaM. Mutation of Thr 495 to alanine increased CaM binding to eNOS in the absence of cell stimulation, whereas the corresponding Asp 495 mutant bound almost no CaM. Accordingly, NO production by the Ala 495 mutant was more sensitive to Ca 2+ /CaM than the aspartate mutant. These results suggest that the dual phosphorylation of Ser 1177 and Thr 495 determines the activity of eNOS in agonist-stimulated endothelial cells. Moreover, the dephosphorylation of Thr 495 by PP1 precedes the phosphorylation of Ser 1177 by CaMKII. The full text of this article is available at http://www.circresaha.org.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In resting endothelial cells, Thr495 is generally phosphorylated”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“The phosphorylation has been attributed to protein kinase C (PKC) (297, 646), and the residue is dephosphorylated by protein phosphatase 1 (PP1)”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“Phosphorylation of Thr495 is a negative regulator of CaM binding to eNOS (297, 407, 646).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Self-citationCloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C. J., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Dynamic activation of endothelial nitric oxide synthase by Hsp90
García‐Cardeña, G., Fan, R., Shah, V. H., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
AMP‐activated protein kinase phosphorylation of endothelial NO synthase
Chen, Z.-P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodríguez‐Crespo, I., Witters, L. A., Power, D. A., de Montellano, P. R. O., & Kemp, B. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01705-0 · Cited by 839
Self-citationNishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S., Uematsu, M., Nerem, R. M., Alexander, R. W., & Murphy, T. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116092 · Cited by 735
García‐Cardeña, G., Fan, R., Stern, D. F., Liu, J., & Sessa, W. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27237 · Cited by 533
Phosphorylation of Endothelial Nitric Oxide Synthase in Response to Fluid Shear Stress
Corson, M. A., James, N. L., Latta, S. E., Nerem, R. M., Berk, B. C., & Harrison, D. G. (1996) · Circulation Research · doi:10.1161/01.res.79.5.984 · Cited by 521
Calcium‐dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin
Busse, R., & Mülsch, A. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80902-u · Cited by 511
Self-citationMolecular cloning and characterization of human endothelial nitric oxide synthase
Marsden, P. A., Schappert, K. T., Chen, H. S., Flowers, M. A., Sundell, C. L., Wilcox, J. N., Lamas, S., & Michel, T. M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80697-f · Cited by 489
Research works printed but not linked: 5
- 10.1161/hyp.25.2.180 · DOI
- 10.1161/res.79.5.984 · DOI
- 10.1161/res.82.6.686 · DOI
- Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [published correction appears in Nature. 1999;400:792]. Nature. 1999;399:597–601.
- 10.1161/res.78.5.750 · DOI
Cited by
Sorted by citations
Soluble endoglin contributes to the pathogenesis of preeclampsia
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K.-H., Yuan, H.-T., Libermann, T. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1429 · Cited by 1,855
“20 ) and increased association of eNOS with Hsp90 (ref”
BackgroundThe role of shear stress in the pathogenesis of atherosclerosis
Cunningham, K. S., & Gotlieb, A. I. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700215 · Cited by 1,190
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase
Fleming, I., & Busse, R. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00323.2002 · Cited by 941
“For example, the agonist-induced activation of the CaM-dependent protein kinase II (CaMKII) is highly dependent on an increase in [Ca2 ]i, whereas the shear stress-induced activation of Akt is not affected by Ca2 removal (28, 36).”
InfluentialSelf-citationHambrecht, R., Adams, V., Erbs, S., Linke, A. H.-P., Kränkel, N., Shu, Y., Baither, Y., Gielen, S., Thiele, H., Gummert, J. F., et al. (2003) · Circulation · doi:10.1161/01.cir.0000074229.93804.5c · Cited by 941
Mattagajasingh, I., Kim, C.-S., Naqvi, A., Yamamori, T., Hoffman, T. A., Jung, S.-B., DeRicco, J., Kasuno, K., & Irani, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704329104 · Cited by 881
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 888
Vascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 875
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Inflammation, Immunity, and Hypertensive End-Organ Damage
McMaster, W. G., Kirabo, A., Madhur, M. S., & Harrison, D. G. (2015) · Circulation Research · doi:10.1161/circresaha.116.303697 · Cited by 708
Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
Andrabi, S. M., Sharma, N. S., Karan, A., Shahriar, S. M. S., Cordon, B., Ma, B., & Xie, J. (2023) · Advanced Science · doi:10.1002/advs.202303259 · Cited by 688
Santos, C. X. C., Tanaka, L. Y., Wosniak, J., & Laurindo, F. R. M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2625 · Cited by 572
Nitric Oxide and Cardiac Function
Massion, P. B., Féron, O., Dessy, C., & Balligand, J. (2003) · Circulation Research · doi:10.1161/01.res.0000088351.58510.21 · Cited by 566
Sessa, W. C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01165 · Cited by 561
“…stress triggering the breakdown of ATP will stimulate AMP kinase (AMPK) to phosphorylate eNOS on S1179 (Chen et al., 1999; Dimmeler et al., 1998; Fleming et al., 2001; Fulton et al., 1999; Harris et al., 2001; Haynes et al., 2000; Igarashi and Michel, 2001; Lin et al., 2003; Michell et al.,…”
BackgroundSampaio, W. O., Santos, R. A. S., Faria-Silva, R., Machado, L. T., Schiffrin, E. L., & Touyz, R. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000251865.35728.2f · Cited by 570
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Besler, C., Heinrich, K., Rohrer, L., Doerries, C., Riwanto, M., Shih, D. M., Chroni, A., Yonekawa, K., Stein, S., Schaefer, N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42946 · Cited by 535
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation
Mount, P. F., Kemp, B. E., & Power, D. A. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.05.023 · Cited by 498
Self-citationBehrendt, D., & Ganz, P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02963-6 · Cited by 509
Balligand, J.-L., Feron, O., & Dessy, C. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2007 · Cited by 477
Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Steinert, J. R., Chernova, T., & Forsythe, I. D. (2010) · The Neuroscientist · doi:10.1177/1073858410366481 · Cited by 471
Molecular mechanisms underlying the activation of eNOS
Fleming, I. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0767-7 · Cited by 437
“The constitutively active kinase which phosphorylates eNOS Thr495 is most probably PKC [42, 74, 77], even though there is some confusion regarding the specific isoform(s) involved.”
BackgroundInfluentialSelf-citationExplaining the Phenomenon of Nitrate Tolerance
Münzel, T., Daiber, A., & Mülsch, A. (2005) · Circulation Research · doi:10.1161/01.res.0000184694.03262.6d · Cited by 424
THE REGULATION AND PHARMACOLOGY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE
Dudzinski, D. M., Igarashi, J., Greif, D. M., & Michel, T. M. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121844 · Cited by 424
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Springer eBooks · doi:10.1007/3-540-32967-6_7 · Cited by 419
“Dephosphorylation of Thr495 precedes the phosphorylation of Ser1177 prior to eNOS activation (Fleming et al. 2001; Harris et al. 2001).”
BackgroundLife history of eNOS: partners and pathways
DUDZINSKI, D., & MICHEL, T. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.023 · Cited by 400
“Endothelial eNOS is subject to several overlappingmodes of post-translational regulatory modifications that provide mechanisms for the dynamic stimulation and inhibition of enzymatic activity in response to physiologic and pathophysiologic stimuli.”
BackgroundZhang, Z., Zhao, L. Q., Zhou, X., Meng, X., & Zhou, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1098725 · Cited by 422
“that IL17A could reduce the production of NO by phosphorylating threonine 495 of endothelial nitric oxide synthase (eNOS) in porcine aortic endothelial cells (87).”
MethodFlow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases
Boo, Y. C., & Jo, H. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00122.2003 · Cited by 395
“It was shown that PKC activation by acute PMA treatments leads to phosphorylation of T497 (39, 74).”
BackgroundInfluentialThomas, S. R., Witting, P. K., & Drummond, G. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2027 · Cited by 383
Thomas, S. R., Chen, K., & Keaney, J. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109107200 · Cited by 381
Physiological role of ROCKs in the cardiovascular system
Noma, K., Oyama, N., & Liao, J. K. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00459.2005 · Cited by 372
“For example, eNOS activity could be regulated in part through association with caveolin-1 (35), porin (107), dynamin (12), G protein-coupled receptors (43), heat shock protein 90 (91), and various protein kinases (14, 23, 30, 34).”
BackgroundInfluentialAging Enhances the Sensitivity of Endothelial Cells Toward Apoptotic Stimuli
Hoffmann, J., Haendeler, J., Aicher, A., Rössig, L., Vasa‐Nicotera, M., Zeiher, A. M., & Dimmeler, S. (2001) · Circulation Research · doi:10.1161/hh2001.097796 · Cited by 360
Self-citationFontana, J. T., Fulton, D. J., Chen, Y., Fairchild, T. A., McCabe, T. J. D., Fujita, N., Tsuruo, T., & Sessa, W. C. (2002) · Circulation Research · doi:10.1161/01.res.0000016837.26733.be · Cited by 340
Davies, P. F., Civelek, M., Fang, Y. H., & Fleming, I. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt101 · Cited by 338
Self-citationNagata, D., Mogi, M., & Walsh, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300643200 · Cited by 331
Fleming, I., Fißlthaler, B., Dixit, M., & Busse, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02541 · Cited by 328
“Proteins in the cell supernatants or immunoprecipitates were heated with SDS-PAGE sample buffer, separated by SDS-PAGE and subjected to western blotting as described (Fleming et al., 2001).”
MethodSelf-citationMünzel, T., Feil, R., Mülsch, A., Lohmann, S. M., Hofmann, F., & Walter, U. (2003) · Circulation · doi:10.1161/01.cir.0000094403.78467.c3 · Cited by 316
Nitric oxide: Ocular blood flow, glaucoma, and diabetic retinopathy
Toda, N., & Nakanishi-Toda, M. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2007.01.004 · Cited by 311
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
Toda, N., & Okamura, T. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.3 · Cited by 309
“It is suggested that the dual phosphorylation of serine and threonine determines the activity of eNOS in agoniststimulated endothelial cells; Ser1177,1179 phosphorylation and Thr495,497 dephosphorylation activate the enzyme (Fleming et al., 2001; Harris et al., 2001).”
BackgroundeNOS Uncoupling in Cardiovascular Diseases - the Role of Oxidative Stress and Inflammation
Karbach, S., Wenzel, P., Waisman, A., Munzel, T., & Daiber, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660748 · Cited by 307
Cervantes-Gracia, K., Llanas-Cornejo, D., & Husi, H. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020022 · Cited by 320
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension
Nguyen, H.-L., Chiasson, V. L., Chatterjee, P., Kopriva, S. E., Young, K. J., & Mitchell, B. M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs422 · Cited by 308
Daiber, A., Xia, N., Steven, S., Oelze, M. W., Hanf, A., Kröller‐Schön, S., Münzel, T. F., & Li, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010187 · Cited by 322
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Steven, S., Oelze, M. W., Hanf, A., Kröller‐Schön, S., Kashani, F., Roohani, S., Welschof, P., Kopp, M., Gödtel‐Armbrust, U., Xia, N., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.009 · Cited by 299
Systemic Oxidative Stress is Associated With Visceral Fat Accumulation and the Metabolic Syndrome
Fujita, K., Nishizawa, H., Funahashi, T., Shimomura, I., & Shimabukuro, M. (2006) · Circulation Journal · doi:10.1253/circj.70.1437 · Cited by 291
Hsp90 and Caveolin Are Key Targets for the Proangiogenic Nitric Oxide–Mediated Effects of Statins
Brouet, A., Sonveaux, P., Dessy, C., Moniotte, S., Balligand, J., & Féron, O. (2001) · Circulation Research · doi:10.1161/hh2201.100319 · Cited by 268
Epoxyeicosatrienoic acids and endothelium-dependent responses
Campbell, W. B., & Fleming, I. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0804-6 · Cited by 265
Self-citationAMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633
Chen, Z., Peng, I.-C., Sun, W., Su, M.-I., Hsu, P.-H., Fu, Y., Zhu, Y., DeFea, K., Pan, S., Tsai, M.-D., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.187567 · Cited by 264
Mikhed, Y., Daiber, A., & Steven, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160715918 · Cited by 257
“They include decreased availability of the eNOS substrate L-arginine or the cofactor tetrahydrobiopterin (BH4), but also phosphorylation state (Ser1177, Thr495, Tyr657) or S-glutathionlyation of the protein (for review see [19]).”
BackgroundInfluentialPaneni, F., Mocharla, P., Akhmedov, A. T., Costantino, S., Osto, E., Volpe, M., Lüscher, T. F., & Cosentino, F. (2012) · Circulation Research · doi:10.1161/circresaha.112.266593 · Cited by 258
CLINICAL AND TOXICOLOGICAL RELEVANCE OF CYP2C9: Drug-Drug Interactions and Pharmacogenetics
Rettie, A. E., & Jones, J. P. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095821 · Cited by 254
Schulz, E., Wenzel, P., Münzel, T. F., & Daiber, A. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4609 · Cited by 258
Bauer, P. M., Fulton, D. J., Boo, Y. C., Sorescu, G. P., Kemp, B. E., Jo, H., & Sessa, W. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211926200 · Cited by 243
Self-citationRole of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system
Miyata, N., & Roman, R. J. (2005) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.41.175 · Cited by 239
“…smooth muscle membranes by activating Ca2+-activated K+-channels (Gebremedhin et al. and Zou et al. were first in 1992 and 1996; Campbell et al., 1996; Popp et al., 1996; Eckman et al., 1998; Hayabuchi et al., 1998; Miura and Gutterman, 1998; Fisslthaler et al., 1999; Fleming et al., 2001).”
Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension
Li, Q., Youn, J.-Y., & Cai, H. “. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000587 · Cited by 244
Williams, I. L., Wheatcroft, S. B., Shah, A. M., & Kearney, M. T. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801995 · Cited by 265
Lin, M. I., Fulton, D. J., Babbitt, R. W., Fleming, I., Busse, R., Pritchard, K. A., & Sessa, W. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302836200 · Cited by 239
Self-citationRafikov, R., Fonseca, F. V., Kumar, S., Pardo, D., Darragh, C., Elms, S. C., Fulton, D. J., & Black, S. M. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0083 · Cited by 235
“Increases in intracellular calcium levels activate CaM that in turn activates CaM kinase II, which also phosphor- ylates S1177 (Fleming et al. 2001).”
BackgroundInfluentialNitric oxide and penile erectile function
Toda, N., Ayajiki, K., & OKAMURA, T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.011 · Cited by 231
Musicki, B., Kramer, M. F., Becker, R. E., & Burnett, A. L. “. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502488102 · Cited by 230
Erdogdu, Ö., Nathanson, D., Sjöholm, Å., Nyström, T., & Zhang, Q. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.022 · Cited by 234
The endothelium: influencing vascular smooth muscle in many ways
Triggle, C. R., Samuel, S. M., Ravishankar, S., Marei, I., Arunachalam, G., & Ding, H. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-073 · Cited by 229
“…617 by either PKA or AKT appears important for the recruitment of eNOS to calmodulin binding, whereas phosphorylation at Thr 495 by PKC attenuates this association (Dimmeler et al. 1999; Fulton et al. 1999; Fleming et al. 2001; Fulton et al. 2001; Michell et al. 2002; Dudzinski and Michel 2007).”
BackgroundFulton, D. J., Fontana, J. T., Sowa, G., Gratton, J., Lin, M. I., Li, K.-X., Michell, B. J., Kemp, B. E., Rodman, D. M., & Sessa, W. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106302200 · Cited by 217
Self-citationPossible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function
Bird, I. M., Zhang, L., & Magness, R. R. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00108.2002 · Cited by 214
“The phosphorylated residues are identified as Ser 116 and Thr 497 (495 in human) as well as Ser 1179 for bovine (equivalent to Ser 1177 for human) (28, 30).”
Stahmann, N., Woods, A., Carling, D., & Heller, R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00383-06 · Cited by 214
“Thrombin has already been shown to activate this kinase (4), and bradykinin, another Gq-protein-coupled stimulus, has been shown to phosphorylate eNOS at serine 1177 via Ca(2) /calmodulindependent kinase II (13).”
BackgroundCaMK4 Gene Deletion Induces Hypertension
Santulli, G., Cipolletta, E., Sorriento, D., Giudice, C. D., Anastasio, A., Monaco, S., Maione, A. S., Condorelli, G., Puca, A. A., Trimarco, B., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.001081 · Cited by 212
Brouet, A., Sonveaux, P., Dessy, C., Balligand, J., & Féron, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101371200 · Cited by 213
Michell, B. J., Harris, M. B., Chen, Z.-P., Ju, H., Venema, V. J., Blackstone, M. A., Huang, W., Venema, R. C., & Kemp, B. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205144200 · Cited by 212
Self-citationTranscriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression
Searles, C. D. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00457.2005 · Cited by 208
Dessy, C., Saliez, J., Ghisdal, P., Daneau, G., Lobysheva, I. I., Frérart, F., Belge, C., Jnaoui, K., Noirhomme, P., Féron, O., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.532960 · Cited by 208
Deep insight into cytokine storm: from pathogenesis to treatment
Nie, J., Zhou, L., Tian, W., Liu, X., Yang, L., Yang, X., Zhang, Y., Wei, S., Wang, D. W., & Wei, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02178-y · Cited by 251
NAD(P)H Oxidase-Derived Reactive Oxygen Species as Mediators of Angiotensin II Signaling
Hanna, I. R., Taniyama, Y., Szöcs, K., Ročić, P., & Griendling, K. K. (2002) · Antioxidants and Redox Signaling · doi:10.1089/152308602762197443 · Cited by 195
Cytochrome P450 pathways of arachidonic acid metabolism
Kroetz, D. L., & Zeldin, D. C. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00007 · Cited by 193
Dephosphorylation of Endothelial Nitric-oxide Synthase by Vascular Endothelial Growth Factor
Kou, R., Greif, D. M., & Michel, T. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204519200 · Cited by 192
Zimmermann, K., Opitz, N., Dedio, J., Renné, C., Müller‐Esterl, W., & Oess, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252345399 · Cited by 192
The NO cascade, eNOS location, and microvascular permeability
Durán, W. N., Breslin, J. W., & Sánchez, F. A. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq139 · Cited by 191
Paradoxes of nitric oxide in the diabetic kidney
Komers, R., & Anderson, S. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00265.2002 · Cited by 190
“For example, phosphorylation of Ser1177/1179 leads to activation of the enzyme (42), whereas phosphorylation of Thr495 has an opposite effect (33).”
BackgroundRecent Advances in Understanding Endothelial Dysfunction in Atherosclerosis
Yang, Z., & Ming, X. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.1.53 · Cited by 191
Cai, H. “., Li, Z., Davis, M. E., Kanner, W. A., Harrison, D. G., & Dudley, S. C. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.325 · Cited by 187
“This effect is associated with a concomitant increase in eNOS phosphorylation at serine 1179 (Fleming et al., 2001).”
InfluentialNdiaye, M., Chataigneau, M., Lobysheva, I. I., Chataigneau, T., & Schini‐Kerth, V. B. (2004) · The FASEB Journal · doi:10.1096/fj.04-2146fje · Cited by 185
Nitric oxide, a protective molecule in the cardiovascular system
Lei, J., Vodovotz, Y., Tzeng, E., & Billiar, T. R. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.09.004 · Cited by 184
eNOS phosphorylation in health and disease
Kolluru, G. K., Siamwala, J. H., & Chatterjee, S. (2010) · Biochimie · doi:10.1016/j.biochi.2010.03.020 · Cited by 183
Structural basis for endothelial nitric oxide synthase binding to calmodulin
Aoyagi, M., Arvai, A. S., Tainer, J. A., & Getzoff, E. D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg078 · Cited by 183
Bell, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(02)00310-3 · Cited by 189
Mann, G. E., Rowlands, D. J., Li, F., deWinter, P., & Siow, R. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.004 · Cited by 184
Predmore, B. L., Kondo, K., Bhushan, S., Zlatopolsky, M., King, A. L., Aragón, J. P., Grinsfelder, D. B., Condit, M. E., & Lefer, D. J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00044.2012 · Cited by 181
“6C), whereas eNOS phosphorylation at Thr495 remained unchanged (P NS; Fig.”
BackgroundInfluentialProatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Rask‐Madsen, C., & King, G. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000155325.41507.e0 · Cited by 176
Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
Funk, S. D., Yurdagul, A., & Orr, A. W. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/569654 · Cited by 176
“(Thr495) blunting eNOS activity [234, 235] and reduces”
Platelet-Derived Nitric Oxide Signaling and Regulation
Gkaliagkousi, Ε., Ritter, J. M., & Ferro, A. (2007) · Circulation Research · doi:10.1161/circresaha.107.158410 · Cited by 175
Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium
Qian, J., & Fulton, D. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00347 · Cited by 185
“…have also been shown to phosphorylate eNOS at S1179, including adenosine monophosphate-activated kinase (AMPK) (Chen et al., 1999), CaM protein kinase II (Fleming et al., 2001), protein kinase A (PKA) (Butt et al., 2000; Gangopahyay et al., 2011), and protein kinase G (PKG) (Butt et al., 2000).”
BackgroundInfluentialEichler, I., Wibawa, J., Grgic, I., Knorr, A., Brakemeier, S., Pries, A. R., Hoyer, J. D., & Köhler, R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705075 · Cited by 174
“In di erent subsets of experiments, vessels were preincubated with 10 mM CLT or 10 mM sulphaphenazole (SPZ), a selective CYP 2C9 inhibitor (Fleming et al., 2001) for 30 min.”
MethodPhosphorylation of Endothelial Nitric-oxide Synthase Regulates Superoxide Generation from the Enzyme
Chen, C., Druhan, L. J., Varadharaj, S., Chen, Y., & Zweier, J. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802269200 · Cited by 173
The eNOS signalosome and its link to endothelial dysfunction
Siragusa, M., & Fleming, I. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1839-0 · Cited by 179
Self-citationRegulation of eNOS Enzyme Activity by Posttranslational Modification
Heiß, E. H., & Dirsch, V. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660745 · Cited by 171
Modulation of endothelial nitric oxide by plant-derived products
Schmitt, C. A., & Dirsch, V. M. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.05.006 · Cited by 177
“agonists – especially those increasing intracellular calcium – Thr can be rapidly dephosphorylated [18,19].”
BackgroundDrew, B. G., Fidge, N., Beaumier-Gallon, G., Kemp, B. E., & Kingwell, B. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306266101 · Cited by 169
Self-citationRamírez‐Sánchez, I., Maya-Ramos, L., Ceballos, G. M., & Villarreal, F. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147892 · Cited by 169
“Thus, calcium-dependent kinases, such as CaMKII, can be activated that in turn activate eNOS [22].”
Daiber, A., & Münzel, T. F. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6376 · Cited by 173
Gélinas, D. S., Bernatchez, P. N., Rollin, S., Bazan, N. G., & Sirois, M. G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704956 · Cited by 166
“However, two recent reports have suggested that the inhibition of PI3K with speci®c inhibitors had no or slight inhibitory e ect on NO release (Fleming et al., 2001; Thuringer et al., 2001).”
BackgroundMethodResult
Metadata
- Authors
- Fleming, I., Fisslthaler, B., Dimmeler, S., Kemp, B. E., & Busse, R.
- Affiliations
- Goethe University Frankfurt (DE)
- Venue
- Circulation Research
- Published
- 2001-06-08
- Volume
- 88
- Issue
- 11
- Pages
- E68-75
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2135297555
- Cited by
- 770
- References
- 38
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 23 · 2020: 18 · 2019: 23 · 2018: 18 · 2017: 29 · 2016: 30 · 2015: 39 · 2014: 34 · 2013: 28 · 2012: 49
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart Foundation of Australia
- Deutsche Forschungsgemeinschaft (SFB 553)
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- endothelial nitric oxide synthase, calmodulin binding, CaMKII, PP1 phosphatase, calyculin A, bradykinin, protein kinase C, nitric oxide production, endothelial cells, dual phosphorylation, calmodulin-dependent kinase II, calmodulin
- MeSH terms
- Animals, Binding Sites, Bradykinin, Calcium, Calmodulin, Cells, Cultured, Coronary Vessels, Endothelium, Vascular, Enzyme Activation, Enzyme Inhibitors, Humans, Phosphorylation, Precipitin Tests, Protein Kinase C, Proto-Oncogene Proteins, Swine, Threonine, Blotting, Western, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Nitric Oxide Synthase, Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, Nitric Oxide Synthase Type III, Calcium-Calmodulin-Dependent Protein Kinase Type 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review